ArticleiScience2026
TRF2 enriched cytoplasmic chromatin drives cGAS-STAT1-mediated inflammation in senescence.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Telomere dysfunction, persistent DNA damage, and chronic inflammation are interconnected hallmarks of cellular senescence, but their molecular links remains poorly defined. Here, we find that senescent cells accumulate telomeric protein TRF2-enriched cytoplasmic chromatin fragments (CCFs), which co-localize with γH2AX and H3K27me3 but lack DNA repair proteins, indicating persistent, unrepaired damage. Inflammatory stress, nuclear lamina dysfunction, and progeroid mutations compromise nuclear integrity, promoting nuclear rupture and extrusion of TRF2-bound nuclear DNA fragments into the cytoplasm. TRF2-enriched CCFs engage the cGAS-STAT1 pathway, sustaining SASP production and reinforcing senescence. Pharmacological inhibition of JAK-STAT or metformin treatment suppressed TRF2-enriched CCFs, reduced cGAS-STAT1 activation, DNA damage markers, and SASP. Our study uncovers TRF2-enriched CCFs as a previously unrecognized source of nuclear-derived DNA in senescent cells. We propose that damaged telomeric DNA extruded into the cytoplasm drives chronic immune activation and inflammation, linking nuclear instability to accelerated aging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.